MK-2461
Catalog No. A11753
MK-2461是一种新型的多靶点激酶抑制剂,优先抑制活化的c-Met受体。
Catalog Num | A11753 |
---|---|
M. Wt | 495.6 |
Formula | C24H25N5O5S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 917879-39-1 |
Synonyms | MK2461 |
SMILES | CN1C=C(C=N1)C2=CN=C3C=CC4=C(C=C(C=C4)NS(=O)(=O)N(C)C[C@@H]5COCCO5)C(=O)C3=C2 |
MK-2461是一种新型的多靶点激酶抑制剂,优先抑制活化的c-Met受体。
Targets
Target | Value |
---|---|
c-Met(M1250T) | IC50: 0.4nM |
c-Met(Y1235D) | IC50: 0.5nM |
c-Met(Y1230H) | IC50: 1.0nM |
c-Met(N1100) | IC50: 1.5nM |
c-Met(Y1230C) | IC50: 1.5nM |
c-Met | IC50: 2.5nM |
RON | IC50: 7nM |
FLT1 | IC50: 10nM |
FLT3 | IC50: 22nM |
PDGFRβ | IC50: 22nM |
Mer | IC50: 24nM |
FGFR2 | IC50: 39nM |
KDR | IC50: 44nM |
TrkA | IC50: 46nM |
FGFR3 | IC50: 50nM |
TrkB | IC50: 61nM |
FGFR1 | IC50: 65nM |
FLT4 | IC50: 78nM |
DRAK1 | IC50: 199nM |
JAK2 | IC50: 225nM |
IRAK4 | IC50: 298nM |
MELK | IC50: 606nM |
RET | IC50: 635nM |
DYRK2 | IC50: 1.143μM |
MLK1 | IC50: 4.303μM |
IRAK1 | IC50: 5.459μM |
Abl | IC50: 7.747μM |
In vitro (25°C) | DMSO | 95 mg/mL (191.7 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80, pH 4 | 14 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.18 mL | 100.89 mL | 201.78 mL |
0.5 mM | 4.04 mL | 20.18 mL | 40.36 mL |
1 mM | 2.02 mL | 10.09 mL | 20.18 mL |
5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
*The above data is based on the productmolecular weight 495.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.